McDermott Will & Schulte advised Théradial, specializes in the distribution of medical devices and pharmaceuticals, on the acquisition of the TauroSept® solution, a reference product in the prevention of central venous catheter-related infections.

This flagship product joins Théradial’s portfolio, strengthening its position in the vascular access market and opening new opportunities at the European and international levels.

The McDermott Will & Schulte team comprised:

• Diana Hund, Partner, on Corporate aspects
• Anne-France Moreau, Partner, Ludivine Rabreau, Alice Villagrasa, Nejma Palasse, associates, on transactional and regulatory aspects
• Charles de Raignac, Counsel, on intellectual property aspects
• Côme de Saint Vincent, Partner, and Paul-Henry de Laguiche, associate, on tax aspects

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.